Welcome to our dedicated page for REGENCY CENTERS SEC filings (Ticker: REG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on REGENCY CENTERS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into REGENCY CENTERS's regulatory disclosures and financial reporting.
Regency Centers Corporation has issued its 2026 proxy statement for a virtual-only annual meeting on May 6, 2026, at 8:00 a.m. Eastern Time. Shareholders of record on March 13, 2026 can vote online, by phone, mail, or during the meeting.
The Board recommends voting FOR three items: election of 11 directors for one-year terms, advisory approval of 2025 executive compensation, and ratification of KPMG LLP as independent auditor for 2026. The proxy highlights 2025 performance, including 5.3% Same Property NOI growth, nearly 8% Nareit FFO per share growth, Core Operating Earnings per share up nearly 7%, over 8 million square feet of leasing with cash rent spreads near 11% and GAAP spreads at 21%, about $318 million of development starts and $538 million of acquisitions, and a common dividend increase of over 7%.
The company emphasizes strong governance—an independent-led board with most directors independent, majority voting, proxy access, no poison pill, and robust risk oversight of areas such as cybersecurity and corporate responsibility. Executive pay remains heavily performance-based, with 2023–2025 performance shares paying at 90% of target on relative total shareholder return.
Regency Centers Corp Executive Chairman Martin E. Stein Jr. reported indirect transactions in the company’s common stock. On March 10 and March 11, the Joan W. Newton 2019 Revocable Trust, after receiving shares from The Regency Group II partnership where he is a general partner, sold 129,490 and 38,000 shares in open-market trades at weighted average prices of $78.334 and $77.2139 per share, totaling 167,490 shares sold. Separately, an irrevocable trust associated with him acquired 6,460 shares as a grant or award. Following these transactions, he continues to hold a significant stake, including 272,133 shares held directly and additional indirect holdings of 24,201, 110,263, and 4,000 shares through various trusts and a family-controlled corporation.
REG submitted a Form 144 notice to sell 38,000 shares of Common Stock under Rule 144. The filing identifies the shares as Founders Shares associated with Martin & Joan Stein. The excerpt also reports prior sales by Martin E. Stein Jr. of 10,000 and 129,490 shares within the past three months.
Regency Centers Corporation reported that co-founder and former Chair Joan Wellhouse Stein Newton has passed away at age 97. She helped lead the company from its founding in 1963 through its 1993 IPO and later served as Chair Emeritus, and is described as one of the most significant female leaders in the U.S. REIT sector.
The company also noted that Executive Chair Martin E. “Hap” Stein, Jr. has advised that, in connection with his mother’s passing and her estate plan, between 150,000 and 200,000 shares of Regency common stock beneficially owned by him may be sold over the next several days in one or more Rule 144 transactions. The company states there is no assurance any sales will occur and emphasizes that these potential transactions do not indicate any change in his role or commitment as Executive Chair.
Martin E. Stein Jr. submitted a Form 144 notice reporting a proposed sale of 10,000 shares of Common Stock on 02/20/2026 with an indicated gross amount of $763,001.00. The filing identifies the shares as founders shares and lists a broker, BofA Securities, Inc..
HERMAN MICHAEL R reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp reported that Senior VP and General Counsel Michael R. Herman received a grant of 7,215 shares of restricted stock on March 4, 2026. The award was granted at a price of $0.00 per share as part of his equity compensation.
All 7,215 shares are held as direct ownership after the transaction. According to the terms, the restricted shares vest in four equal installments of 25% each year, beginning on March 4, 2027.
REGENCY CENTERS CORP Principal Accounting Officer Terah L. Devereaux received a grant of 3,173 restricted stock shares. The Form 4 reports this as an acquisition awarded on March 4, 2026 at a stated price of $0.00 per share.
The award vests over time, with 25% of the restricted stock scheduled to vest each year beginning on March 4, 2027. Following this grant, Devereaux is reported as directly owning 3,173 shares related to this award.
Regency Centers Corporation filed a current report to notify investors that it has made an updated investor presentation available. The presentation will be used at various conferences and meetings beginning on March 2, 2026 and over the following weeks.
The updated materials can be accessed through the investor relations section of Regency’s website at investors.regencycenters.com. The company notes that this presentation is being furnished under a disclosure item that is not treated as formally filed under securities laws, which limits its exposure to certain legal liabilities.
Regency Centers Corp Executive Chairman Martin E. Stein Jr. sold 10,000 shares of common stock in an open-market transaction at an average price of $76.3001 per share. The sale used a weighted average price, with individual trades executed between $76.10 and $76.42. After the sale, he directly holds 272,133 common shares, in addition to several indirect holdings through trusts, a family-controlled corporation, and general partnerships.
Regency Centers Corporation reported that its operating partnership, Regency Centers, L.P., completed a public offering of $450 million principal amount of 4.50% senior unsecured notes due 2033, priced at 99.376% of principal. The notes are unsecured, unsubordinated obligations of the partnership and are fully guaranteed by Regency.
The notes mature on March 15, 2033 and pay interest at 4.50% per year, with semiannual payments each March 15 and September 15, beginning September 15, 2026. Regency expects estimated net proceeds of about $443.3 million after underwriting discounts and expenses.
Regency plans to use the proceeds to reduce the balance on its line of credit, repay $100 million of 3.81% notes due May 11, 2026 at maturity, and for general corporate purposes, including capital expenditures, development and redevelopment projects, and future repayment of other outstanding debt.